Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia
Condition(s) studied
Investigational drug(s) / intervention(s)
Hypnotic Virtual reality: Hypnotic Virtual reality mask Deepsen® with age-appropriate software Birdy®
Interactive virtual reality: Interactive virtual reality mask Deepsen® with age-appropriate software Birdy®
Standard method: Use of local anesthesic cream + Nurse and/or parents distraction +/- anxioloytic gas
Study summary
Main objective:
Evaluate the effectiveness of the repeated use of interactive or hypnotic virtual reality compared to standard treatment, on pain, during each needle placement on PAC for 3 months on children or adolescents (6 to 16 years old) with acute leukemia
Hypothesis:
Repeated use over 3 months of hypnotic or interactive virtual reality provides more benefits in terms of :
* pain management
* anxiety of the child and his parents
* satisfaction of the child's care, of his parents and of the caregivers compared to the standard method when inserting a needle into an implantable port in the pediatric oncology department or day hospital.
Eligibility
Primary outcome measure(s)
- Children's pain self-evaluation — 15 minutes after the care
Self-evaluation of children's pain with the visual analog scale in vertical position. Quote from 0 to 10 with 10 being the worst score.
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Bordeaux | Bordeaux | France | Recruiting |
| CHU de Clermont-Ferrand | Clermont-Ferrand | France | Recruiting |
| Assistance Publique - Hôpitaux de Marseille | Marseille | France | Recruiting |
| CHU de Toulouse | Toulouse | France | Recruiting |
More University Hospital, Clermont-Ferrand trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06697275 on ClinicalTrials.gov ↗ ← All trials in France